Progress in cardiovascular disease: technical considerations in cardiac resynchronization therapy
- PMID: 16517246
- DOI: 10.1016/j.pcad.2006.01.001
Progress in cardiovascular disease: technical considerations in cardiac resynchronization therapy
Abstract
Cardiac resynchronization therapy (CRT) has been shown to improve symptoms, ventricular function, and survival in patients with left ventricular systolic dysfunction and ventricular conduction delay. Patients with moderate to severe drug-refractory heart failure symptoms along with ventricular dyssynchrony, manifested as prolongation of the QRS duration on the surface electrocardiogram, benefit from CRT. Owing to the growing awareness and application of CRT, a large number of patients have been identified as candidates for this therapy, making it necessary for clinicians involved in the care of such patients to be adequately knowledgeable of various aspects of CRT implementation. In particular, clinicians involved in the care of these patients must be aware of the practical considerations in preparing patients for the implantation procedure, careful surveillance for early or late procedure-related complications, and knowledge of the fundamental device features so as to tailor therapeutic and programming techniques to improve long-term response to CRT. This review addresses the technical considerations of the implantation procedure and device function with emphasis on the initial and long-term programming to ensure optimal delivery of CRT.
Similar articles
-
Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.Am J Cardiol. 2009 May 1;103(9):1280-4. doi: 10.1016/j.amjcard.2009.01.023. Am J Cardiol. 2009. PMID: 19406272
-
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1. J Am Coll Cardiol. 2009. PMID: 19800193 Clinical Trial.
-
Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.J Med Assoc Thai. 2007 Jul;90(7):1458-66. J Med Assoc Thai. 2007. PMID: 17710992
-
Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.Nat Clin Pract Cardiovasc Med. 2006 Apr;3(4):213-9. doi: 10.1038/ncpcardio0505. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16568130 Review.
-
Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Interact Cardiovasc Thorac Surg. 2008. PMID: 18541605 Review.
Cited by
-
Long-term cerebral thromboembolic complications of transapical endocardial resynchronization therapy.J Interv Card Electrophysiol. 2017 Mar;48(2):113-120. doi: 10.1007/s10840-016-0206-6. Epub 2016 Nov 12. J Interv Card Electrophysiol. 2017. PMID: 27838871 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials